SEC Comment Letter 0000000000-24-003597 to VACCINEX, INC. (VCNX) (CIK 0001205922) (VCNX)
VACCINEX, INC. (VCNX) (CIK 0001205922)
Date: April 3, 2024 · CIK: 0001205922 · Accession: 0000000000-24-003597
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278467
Letter
United States securities and exchange commission logo April 3, 2024 Maurice Zauderer, Ph.D. President and Chief Executive Officer Vaccinex, Inc. 1895 Mount Hope Avenue Rochester, NY 14620 Re:Vaccinex, Inc. Registration Statement on Form S-3 Filed April 2, 2024 File No. 333-278467 Dear Maurice Zauderer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nick Hoover
Show Raw Text
United States securities and exchange commission logo
April 3, 2024
Maurice Zauderer, Ph.D.
President and Chief Executive Officer
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, NY 14620
Re:Vaccinex, Inc.
Registration Statement on Form S-3
Filed April 2, 2024
File No. 333-278467
Dear Maurice Zauderer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nick Hoover